Oxidative Stress, Hypertension and an FGF-binding Protein
氧化应激、高血压和 FGF 结合蛋白
基本信息
- 批准号:7218285
- 负责人:
- 金额:$ 33.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-09-01 至 2011-08-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS-Associated NephropathyAcute Kidney FailureAddressAdultAngiotensin IIAnimalsBindingBinding ProteinsBiochemicalBlood PressureBlood VesselsCell SurvivalCellsChemical InjuryCircadian RhythmsComplementCultured CellsDevelopmentEndotheliumEpithelialEpithelial CellsEpitheliumExtracellular MatrixFibroblast Growth FactorFibroblast Growth Factor 1Fibroblast Growth Factor 2Fibroblast Growth Factor ReceptorsFigs - dietaryG Protein-Coupled Receptor SignalingG-Protein-Coupled ReceptorsGene ExpressionGenerationsHumanHypertensionImmunoprecipitationIn VitroInjuryKidneyKnockout MiceMAPK14 geneMAPK8 geneMaintenanceMalignant NeoplasmsMass Spectrum AnalysisMesenchymalMitogen-Activated Protein KinasesModelingMonitorMusNormal tissue morphologyOrganOxidative StressPathway interactionsPatientsProteinsReactive Oxygen SpeciesReadingReceptor Protein-Tyrosine KinasesReceptor SignalingRegulationResearch DesignResearch PersonnelRoleSamplingSeriesSignal TransductionSignal Transduction AlterationSignaling ProteinSkinSmooth Muscle MyocytesStressSuperoxide DismutaseSuperoxidesTetracyclineTetracycline ControlTetracyclinesTissuesTransgenesTransgenic MiceTubular formationTwo-Dimensional Gel ElectrophoresisUp-RegulationWorkWound Healingblood pressure regulationcell typedayexperimental analysisextracellularin vivomimeticspermanent cell lineprogramsreceptorrepairedresearch studyresponserole modelselective expressiontempoltransgene expression
项目摘要
Fibroblast growth factors (FGF-1 or -2) are present at significant concentrations in most normal tissues in
the adult. However, these FGFs are immobilized in an inactive state on the extracellular matrix and it is only
poorly understood how they are solubilized and activated to reach their extracellular receptors. One
mechanism through which FGFs can be mobilized is by binding to secreted binding proteins (BPs) and we
showed that BP1 can enhance the activity of locally stored, immobilized FGFs. BP1 expression is controlled
by stress pathways in cultured cells and found upregulated after wounding, toxic or infectious injury of the
skin or kidneys. BP1 expression in mice carrying an inducible BP1 transgene caused a significant rise in
mean arterial blood pressure (MAP) by +30 mm Hg within two days of transgene induction and analysis of
vascular contractility showed a sensitization to angiotensin II. The rise of MAP after BP1 transgene
expression was inhibited by systemic administration of the superoxide dismutase mimetic Tempol
suggesting an essential role of oxidative stress. We hypothesize that BP1/FGF signaling modulates the
sensitivity of blood vessels towards contractile signaling and propose to study this under the following aims:
Aim 1. To evaluate the contribution of FGF-2 or other FGFs to the BP1-induced hypertensive effect. We will
study blood pressure, vessel contractility and renal tubular function in FGF-2(-/-) mice that are crossed with
mice carrying an inducible BP1 transgene. Systemic administration of BP1 and FGF-2 will complement this.
Aim 2. To study the contribution of kidney expression of BP1 to blood pressure regulation, vessel
contractility and renal tubular function we will use mice harboring a HoxB7-controlled, tetracycline inducible
BP1 transgene. To evaluate the role of endogenous BP1 to oxidative stress-regulated blood pressure, we
will generate mice that are null for BP1 expression.
Aim 3. To study the intracellular cross-talk between BP1 / FGF signaling and G-protein coupled receptor
pathways we will monitor signal transduction and phenotypic effects in preglomular smooth muscle cells
from experimental animals. Biochemical signaling via known integrators of the pathways (i.e. MAPKs) and
proliferation/cell survival and superoxide generation will be used as read-outs. Mass spectrometry to identify
new signaling proteins in the cross-talk will complement this.
成纤维细胞生长因子(FGF-1或-2)存在于大多数正常组织中
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Anton Wellstein其他文献
Anton Wellstein的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Anton Wellstein', 18)}}的其他基金
Oxidative Stress, Hypertension and an FGF-binding protein
氧化应激、高血压和 FGF 结合蛋白
- 批准号:
8148030 - 财政年份:2010
- 资助金额:
$ 33.47万 - 项目类别:
Pancreas Cancer Specialized Prog of Research Excellence
胰腺癌专业卓越研究计划
- 批准号:
6800656 - 财政年份:2003
- 资助金额:
$ 33.47万 - 项目类别:
Pancreas Cancer Specialized Program of Research Excelle*
Excelle 胰腺癌专门研究计划*
- 批准号:
6937066 - 财政年份:2003
- 资助金额:
$ 33.47万 - 项目类别:
Pancreas Cancer Specialized Program of Research Excelle*
Excelle 胰腺癌专门研究计划*
- 批准号:
7108549 - 财政年份:2003
- 资助金额:
$ 33.47万 - 项目类别:
Pancreas Cancer Specialized Program of Research Excelle*
Excelle 胰腺癌专门研究计划*
- 批准号:
7247994 - 财政年份:2003
- 资助金额:
$ 33.47万 - 项目类别:
Pancreas Cancer Specialized Program of Research Excelle*
Excelle 胰腺癌专门研究计划*
- 批准号:
6804998 - 财政年份:2003
- 资助金额:
$ 33.47万 - 项目类别:
相似海外基金
Acute kidney failure: investigation and treatment of ki dney cell injury
急性肾衰竭:肾细胞损伤的调查和治疗
- 批准号:
nhmrc : 901011 - 财政年份:1990
- 资助金额:
$ 33.47万 - 项目类别:
NHMRC Project Grants
Acute kidney failure: new methods of investigation and treatment
急性肾衰竭:研究和治疗的新方法
- 批准号:
nhmrc : 891081 - 财政年份:1989
- 资助金额:
$ 33.47万 - 项目类别:
NHMRC Project Grants














{{item.name}}会员




